These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22895790)

  • 21. Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors.
    Bhat R; Tummalapalli SR; Rotella DP
    J Med Chem; 2014 Nov; 57(21):8718-28. PubMed ID: 25141341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells.
    Samant RS; Clarke PA; Workman P
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6834-9. PubMed ID: 24760825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cytosolic prostaglandin E2 synthase by 90-kDa heat shock protein.
    Tanioka T; Nakatani Y; Kobayashi T; Tsujimoto M; Oh-ishi S; Murakami M; Kudo I
    Biochem Biophys Res Commun; 2003 Apr; 303(4):1018-23. PubMed ID: 12684036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
    Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
    Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
    Ono N; Yamazaki T; Nakanishi Y; Fujii T; Sakata K; Tachibana Y; Suda A; Hada K; Miura T; Sato S; Saitoh R; Nakano K; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
    Cancer Sci; 2012 Feb; 103(2):342-9. PubMed ID: 22050138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.
    Li Y; Zhang T; Schwartz SJ; Sun D
    Nutr Cancer; 2011; 63(7):1151-9. PubMed ID: 21875325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models.
    Jensen MR; Schoepfer J; Radimerski T; Massey A; Guy CT; Brueggen J; Quadt C; Buckler A; Cozens R; Drysdale MJ; Garcia-Echeverria C; Chène P
    Breast Cancer Res; 2008; 10(2):R33. PubMed ID: 18430202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of HSP90 client proteins in human breast cancer.
    Shipp C; Watson K; Jones GL
    Anticancer Res; 2011 Jun; 31(6):2095-101. PubMed ID: 21737627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tosylcyclonovobiocic acids promote cleavage of the hsp90-associated cochaperone p23.
    Radanyi C; Le Bras G; Bouclier C; Messaoudi S; Peyrat JF; Brion JD; Alami M; Renoir JM
    Biochem Biophys Res Commun; 2009 Feb; 379(2):514-8. PubMed ID: 19118525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organelle-specific Hsp90 inhibitors.
    Seo YH
    Arch Pharm Res; 2015 Sep; 38(9):1582-90. PubMed ID: 26195286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
    Li L; Wang L; You QD; Xu XL
    J Med Chem; 2020 Mar; 63(5):1798-1822. PubMed ID: 31663736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery.
    Ding G; Chen P; Zhang H; Huang X; Zang Y; Li J; Li J; Wong J
    J Biol Chem; 2016 Sep; 291(38):20125-35. PubMed ID: 27489107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond.
    Georgakis GV; Younes A
    Future Oncol; 2005 Apr; 1(2):273-81. PubMed ID: 16555999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells.
    Rouhi A; Miller C; Grasedieck S; Reinhart S; Stolze B; Döhner H; Kuchenbauer F; Bullinger L; Fröhling S; Scholl C
    Oncotarget; 2017 Jan; 8(5):7678-7690. PubMed ID: 28032595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syntheses and discovery of a novel class of cinnamic hydroxamates as histone deacetylase inhibitors by multimodality molecular imaging in living subjects.
    Chan CT; Qi J; Smith W; Paranol R; Mazitschek R; West N; Reeves R; Chiosis G; Schreiber SL; Bradner JE; Paulmurugan R; Gambhir SS
    Cancer Res; 2014 Dec; 74(24):7475-86. PubMed ID: 25320008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers.
    Chandarlapaty S; Sawai A; Ye Q; Scott A; Silinski M; Huang K; Fadden P; Partdrige J; Hall S; Steed P; Norton L; Rosen N; Solit DB
    Clin Cancer Res; 2008 Jan; 14(1):240-8. PubMed ID: 18172276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases.
    Yao Q; Nishiuchi R; Li Q; Kumar AR; Hudson WA; Kersey JH
    Clin Cancer Res; 2003 Oct; 9(12):4483-93. PubMed ID: 14555522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay strategies for the discovery and validation of therapeutics targeting Brugia pahangi Hsp90.
    Taldone T; Gillan V; Sun W; Rodina A; Patel P; Maitland K; O'Neill K; Chiosis G; Devaney E
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e714. PubMed ID: 20559560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
    Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y
    Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leishmania donovani P23 protects parasites against HSP90 inhibitor-mediated growth arrest.
    Hombach A; Ommen G; Sattler V; Clos J
    Cell Stress Chaperones; 2015 Jul; 20(4):673-85. PubMed ID: 25948161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.